Five things oculoplastic surgeons should know about the preoperative assessment of hemostasis

Ophthalmic Plastic and Reconstructive Surgery

Volumn 18, Issue 6, 2002, Pages 396-401

  Pruthi, Rajiv K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; ARGATROBAN; CELECOXIB; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DESMOPRESSIN; FIBRINOGEN; HEMOSTATIC AGENT; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MELOXICAM; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROCOAGULANT; PROTEIN C; RECEPTOR BLOCKING AGENT; ROFECOXIB; THROMBIN; THROMBIN INHIBITOR; TICLOPIDINE; UNINDEXED DRUG; VON WILLEBRAND FACTOR; WARFARIN;

BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; EYE SURGERY; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PLASTIC SURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOCYTE FUNCTION; THROMBOSIS PREVENTION; VON WILLEBRAND DISEASE;

EID: 0036848843     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-200211000-00002     Document Type: Review

References (25)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 1991;30:10363-70.
2. Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999;5:40-8.
3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987;69:454-9.
4. Duke WW. The pathogenesis of purpura hemorrhagica with especial reference to the part played by blood-platelets. Arch Intern Med 1912;10:445-69.
5. Ivy AC, Shapiro PF, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstet 1935;60:781-4.
6. Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998;133:134-9.
7. Marshall PW, Williams AJ, Dixon RM, et al. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997;44:151-5.
8. Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000;111:733-44.
9. Abildgaard CF, Suzuki Z, Harrison J, et al. Serial studies in von Willebrand's disease: Variability versus "variants." Blood 1980;56:712-6.
10. Hunault M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 2000;26:401-5.
11. Crofford LJ. COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 1997;24(Suppl 49):15-9.
12. IIIIn-labelled human platelets. Eur J Nucl Med 1985;10:522-7.
13. Parkin B, Manners R. Aspirin and warfarin therapy in oculoplastic surgery. Br J Ophthalmol 2000;84:1426-7.
14. Kallio H, Paloheimo M, Maunuksela EL. Haemorrhage and risk factors associated with retrobulbar/peribulbar block: A prospective study in 1383 patients. Br J Anaesth 2000;85:708-11.
15. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol 1997;24(Suppl 49):9-14.
16. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100:1667-72.
17. Stone LS, Kline OR Jr, Sklar C. Intraocular lenses and anticoagulation and antiplatelet therapy. J Am Intraocul Implant Soc 1985;11:165-8.
18. Hall DL, Steen WH Jr, Drummond JW, et al. Anticoagulants and cataract surgery. Ophthal Surg 1988;19:221-2.
19. Gainey SP, Robertson DM, Fay W, et al. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol 1989;108:142-6.
20. Bartley GB. Oculoptastic surgery in patients receiving warfarin: Suggestions for management. Ophthal Plast Reconstr Surg 1996;12:229-30.
21. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336:1506-11.
22. Weitz JL. Low-molecular-weight heparins. N Engl J Med 1997;337:688-98.
23. Pineo GF, Hull RD. Thrombin inhibitors as anticoagulant agents. Curr Opin Hematol 1999;6:298-303.
24. Fremes SE, Wong BI, Lee E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994;58:1580-8.
25. Palaia DA, Rosenberg MH, Bonanno PC. The use of DDAVP desmopressin reduces the incidence of microhematomas after facioplasty. Ann Plast Surg 2001;46:463-6.